Delivery Order SPE2DB22D1202-SPE2DB24FVJP9

Award Date 8/1/24
Potential Completion Date 8/22/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TAGRISSO 80 MG TABLET 30S, a pharmaceutical product. The contract has a ceiling value of $21,325.14 and a period of performance ending on July 14, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,871.50 firm fixed-price contract is for the delivery of TAGRISSO 40 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 17, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of TAGRISSO 80 MG TABLET 30S, a pharmaceutical product. The $21,077.60 firm fixed price contract has an ultimate completion date of October 18, 2024. The award does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this delivery order. The company holds several indefinite delivery contracts (IDCs) with the DLA...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TAGRISSO 80 MG TABLET 30S, a specialty medication, with a ceiling value of $10,662.57 and a completion date of February 13, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of TAGRISSO 40 MG TABLET 30S, a pharmaceutical product. The contract has a ceiling value of $21,016.64 and is a firm fixed-price delivery order. The period of performance ends on September 4, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TAGRISSO 80 MG TABLET 30S, a pharmaceutical product, with a total contract ceiling value of $21,325.14 and a period of performance through June 30, 2025. The contract is a firm-fixed price arrangement and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $10,538.79 firm fixed price contract is for the supply of TAGRISSO 80 MG TABLET 30S, a pharmaceutical product. The ultimate completion date is September 3, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract as well as several Indefinite Delivery Contracts (IDCs) by various federal agencies,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TAGRISSO 40 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $20,347.75 and an ultimate completion date of November 7, 2024. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of TAGRISSO 80 MG TABLET 30S, a pharmaceutical product. The order is valued at $10,538.79 and has a firm fixed price pricing type. The contract has an ultimate completion date of October 10, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, leveraging its extensive supply chain network. The company holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,508.31, is for the supply of TAGRISSO 40 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of September 30, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FVJP9
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of TAGRISSO 80 MG TABLET 30S, a pharmaceutical product. The contract is a firm fixed-price agreement with a ceiling value of $10,538.79 and an ultimate completion date of August 22, 2024. There is no set-aside designation mentioned in the information provided. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is the prime contractor for this award. The company holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000, respectively, for the supply of a wide range of medical commodities and prescription drugs to support military treatment programs, veterans' healthcare, and other federal healthcare beneficiaries.

Generated 10/31/24, 10:43 AM